Skip to main content
Top
Published in: Cancer Causes & Control 2/2019

01-02-2019 | Brief Report

Identifying optimal approaches to scale up colorectal cancer screening: an overview of the centers for disease control and prevention (CDC)’s learning laboratory

Authors: Florence K. L. Tangka, Sujha Subramanian, Sonja Hoover, Christen Lara, Casey Eastman, Becky Glaze, Mary Ellen Conn, Amy DeGroff, Faye L. Wong, Lisa C. Richardson

Published in: Cancer Causes & Control | Issue 2/2019

Login to get access

Abstract

Use of recommended screening tests can reduce new colorectal cancers (CRC) and deaths, but screening uptake is suboptimal in the United States (U.S.). The Centers for Disease Control and Prevention (CDC) funded a second round of the Colorectal Cancer Control Program (CRCCP) in 2015 to increase screening rates among individuals aged 50–75 years. The 30 state, university, and tribal awardees supported by the CRCCP implement a range of multicomponent interventions targeting health systems that have low CRC screening uptake, including low-income and minority populations. CDC invited a select subset of 16 CRCCP awardees to form a learning laboratory with the goal of performing targeted evaluations to identify optimal approaches to scale-up interventions to increase uptake of CRC screening among vulnerable populations. This commentary provides an overview of the CRCCP learning laboratory, presents findings from the implementation of multicomponent interventions at four FQHCs participating in the learning laboratory, and summarizes key lessons learned on intervention implementation approaches. Lessons learned can support future program implementation to ensure scalability and sustainability of the interventions as well as guide future implementation science and evaluation studies conducted by the CRCCP learning laboratory.
Literature
4.
go back to reference Seeff LC, DeGroff A, Joseph DA, Royalty J, Tangka FK, Nadel MR, Plescia M (2013) Moving forward: using the experience of the CDCs’ Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts. Cancer 119(Suppl 15):2940–2946. https://doi.org/10.1002/cncr.28155 CrossRefPubMed Seeff LC, DeGroff A, Joseph DA, Royalty J, Tangka FK, Nadel MR, Plescia M (2013) Moving forward: using the experience of the CDCs’ Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts. Cancer 119(Suppl 15):2940–2946. https://​doi.​org/​10.​1002/​cncr.​28155 CrossRefPubMed
6.
go back to reference DeGroff A, Sharma K, Satsangi A, Kenney K, Joseph D, Ross K, Leadbetter S, Helsel B, Kammerer B, Firth R, Rockwell T, Short W, Tangka F, Wong F, Richardson L (2018) Implementing evidence-based interventions in U.S. Healthcare Systems to increase colorectal cancer screening: year 1 results of the CDC Colorectal Cancer Control Program. Prev Chronic Dis (Paper Under Review) DeGroff A, Sharma K, Satsangi A, Kenney K, Joseph D, Ross K, Leadbetter S, Helsel B, Kammerer B, Firth R, Rockwell T, Short W, Tangka F, Wong F, Richardson L (2018) Implementing evidence-based interventions in U.S. Healthcare Systems to increase colorectal cancer screening: year 1 results of the CDC Colorectal Cancer Control Program. Prev Chronic Dis (Paper Under Review)
11.
go back to reference Subramanian S, Tangka F, Hoover S, Cole Beebe ME, DeGroff A, Royalty J et al (2013) Costs of planning and implementing federally funded colorectal cancer screening. Cancer 119(Suppl. 15):2855–2862CrossRefPubMed Subramanian S, Tangka F, Hoover S, Cole Beebe ME, DeGroff A, Royalty J et al (2013) Costs of planning and implementing federally funded colorectal cancer screening. Cancer 119(Suppl. 15):2855–2862CrossRefPubMed
12.
go back to reference Trogdon JG, Ekwueme DU, Subramanian S, Crouse W (2014) Economies of scale in federally-funded, state-organized public health programs: results from the National Breast and Cervical Cancer Early Detection Programs. Health Care Manag Sci 17(4):321–330CrossRefPubMed Trogdon JG, Ekwueme DU, Subramanian S, Crouse W (2014) Economies of scale in federally-funded, state-organized public health programs: results from the National Breast and Cervical Cancer Early Detection Programs. Health Care Manag Sci 17(4):321–330CrossRefPubMed
Metadata
Title
Identifying optimal approaches to scale up colorectal cancer screening: an overview of the centers for disease control and prevention (CDC)’s learning laboratory
Authors
Florence K. L. Tangka
Sujha Subramanian
Sonja Hoover
Christen Lara
Casey Eastman
Becky Glaze
Mary Ellen Conn
Amy DeGroff
Faye L. Wong
Lisa C. Richardson
Publication date
01-02-2019
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 2/2019
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-018-1109-x

Other articles of this Issue 2/2019

Cancer Causes & Control 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine